Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease

Fig. 2

Difference plots for original immunodepletion (ImDe) method and new immunoaffinity (IAMS) method biomarker concentrations. Panel A is for APOA4, panel B for CD5L and panel C for IBP3. These difference plots show the agreement between methods for each biomarker, after IAMS concentrations were adjusted based on the mean bias determined from Bland Altman plot analysis. LoA is Limits of Agreement. 95%CI is the 95% Confidence Interval

Back to article page

Clinical Proteomics

ISSN: 1559-0275